Stockreport
Argenx SE reports 9M results [Seeking Alpha]
US:NASDAQ Investor Relations: investor.argenx.com/phoenix.zhtml?c=254223&p=irol-presentations
PDF
Argenx SE reports 9M resultsArgenx SE (Pending:ARGX): 9M Comprehensive loss of €16.46MRevenue of €28.42B (+170.2% Y/Y)Press ReleaseNow read:MannKind Heat Check »
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | ARGX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ARGX alerts
ARGX alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARGX alerts
High impacting ARGENX SE ADS news events
Weekly update
A roundup of the hottest topics
ARGX
NEWS
NEWS
- argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.[MarketBeat]
- argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $104.00 price target on the stock.[MarketBeat]
- argenx SE - (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $125.00 price target on the stock, down previously from $130.00.[MarketBeat]
- argenx SE - (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus.[MarketBeat]
- argenx announces new cusatuzumab (ARGX-110) AML data in abstracts published in connection with 60th American Society of Hematology Annual Meeting and Exposition[GlobeNewswire]
- More
ARGX
SEC Filings
SEC Filings
- 11/1/18 - Form 6-K
- 10/25/18 - Form 6-K
- 10/9/18 - Form 6-K
- ARGX's page on the SEC website
- More